Recent Asian expert consensus has reported that the percentage of EGFR alterations in lung adenocarcinoma is higher among East Asian compared to Western population (40–55% vs. 12–25%), while KRAS, BRAF, and ROS1 are lower, with HER2 and MET are nearly similar [28]. This evidence concerns the gene ERBB2 and lung adenocarcinoma.